GRCE — GRACE THERAPEUTICS INC
As of Q2 2026, 7 SEC-registered investment managers reported holding GRCE (GRACE THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $2.40M across 1.06M shares. That is +10.2% by share count (+97.95K shares) versus the previous quarter, while reported value moved -46.0%. Ownership is concentrated: the five largest holders account for 98.9% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 opened new positions, 2 added to existing stakes, 1 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
GRCE is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| D. E. Shaw & Co history | Q4 2024 | 27.33M | $26.16M | 0.02% | Add |
| Franklin Resources history | Q1 2024 | 30.15M | $22.09M | 0.01% | Reduce |
| Amundi US history | Q4 2024 | 3.43M | $3.30M | 0.00% | Hold |
| Wellington Management Group history | Q1 2022 | 2.12M | $1.99M | 0.00% | Hold |
| Point72 Asset Management history | Q3 2024 | 2.00M | $1.71M | 0.00% | New |
| Vanguard Group history | Q4 2025 | 423.98K | $1.48M | 0.00% | Add |
| Deutsche Bank AG history | Q3 2021 | 999.00K | $1.15M | 0.00% | New |
| Renaissance Technologies history | Q1 2026 | 243.91K | $1.13M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 494.70K | $1.12M | 0.00% | Hold |
| Citadel Advisors history | Q2 2026 | 402.24K | $913.09K | 0.00% | Add |
| Marshall Wace history | Q1 2026 | 91.42K | $423.26K | 0.00% | New |
| Two Sigma Investments history | Q2 2026 | 96.89K | $219.94K | 0.00% | New |
| BNY Mellon history | Q3 2023 | 200.00K | $162.37K | 0.00% | Hold |
| BlackRock Inc history | Q2 2026 | 37.53K | $85.20K | 0.00% | New |
| UBS Group AG history | Q2 2026 | 16.78K | $38.08K | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 9.45K | $21.45K | 0.00% | Add |
| Citigroup Inc history | Q3 2025 | 2.76K | $8.19K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 1.80K | $4.09K | 0.00% | Hold |
| JPMorgan Chase & Co history | Q1 2025 | 15 | $34 | 0.00% | Reduce |
New Positions (Q2 2026)
- Two Sigma Investments 96.89K sh · $219.94K
- BlackRock Inc 37.53K sh · $85.20K
Fully Exited (vs previous quarter)
- Renaissance Technologies sold 243.91K sh · $1.13M
- Marshall Wace sold 91.42K sh · $423.26K
Fund Position History — shares by quarter (top 19 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bank of America Corp | 46.00K | 1.04M | 1.04M | 992.00K | — | — | 328.00K | — | — | — | — | — | 60.00K | 554.70K | 494.70K | 494.70K | 494.70K | 494.70K | 494.72K | 494.70K |
| Citadel Advisors | 124.95M | 78.20M | 23.55M | — | 1.75M | 290.00K | 15.40M | — | — | — | — | — | — | 23.66K | 38.40K | 34.38K | 27.27K | 42.30K | 98.74K | 402.24K |
| Two Sigma Investments | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 96.89K |
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | — | 2.42M | 2.82M | — | — | — | — | — | 37.53K |
| UBS Group AG | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 26.30K | 16.78K |
| Morgan Stanley | 4.13M | 4.21M | 4.21M | 5.39M | 3.37M | 3.87M | 3.74M | 3.60M | 3.05M | 3.59M | 1.42M | 4.86M | 2.92M | 45.88K | 1.85K | 1.85K | 1.85K | 25.45K | 4.55K | 9.45K |
| Wells Fargo & Co | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.80K | 1.80K |
| Renaissance Technologies | — | — | — | — | — | — | — | — | — | — | — | — | — | 42.98K | 42.18K | 27.62K | 84.56K | 129.78K | 243.91K | — |
| Citigroup Inc | — | — | — | — | — | 25.00K | 550.00K | 550.00K | 500.00K | 500.00K | — | — | 3.50M | — | — | 1 | 2.76K | — | — | — |
| Marshall Wace | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 91.42K | — |
| Vanguard Group | — | — | — | — | — | — | — | — | — | — | — | — | — | 225.00K | 255.40K | 409.10K | 409.10K | 423.98K | — | — |
| Point72 Asset Management | — | — | — | — | — | — | — | — | — | — | — | — | 2.00M | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | — | 191.60K | 4.60K | 70.40K | — | — | 1.60K | — | 2.40K | 2.40K | — | — | 3.50M | 17 | 15 | — | — | — | — | — |
| Deutsche Bank AG | 999.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Amundi US | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 3.43M | 3.43M | 3.43M | 3.43M | 3.43M | 3.43M | 3.43M | — | — | — | — | — | — |
| BNY Mellon | — | — | — | — | 300.00K | 100.00K | 200.00K | 200.00K | 200.00K | — | — | — | — | — | — | — | — | — | — | — |
| D. E. Shaw & Co | — | — | — | — | — | — | 34.36M | 34.36M | 38.12M | 38.12M | 38.12M | 40.62M | 17.23M | 27.33M | — | — | — | — | — | — |
| Franklin Resources | 48.00M | 48.00M | 48.00M | 48.00M | 48.00M | 48.00M | 44.00M | 44.00M | 44.00M | 44.00M | 30.15M | — | — | — | — | — | — | — | — | — |
| Wellington Management Group | — | 2.12M | 2.12M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details